CDC Vaccine Policy Recommendations Halted Amidst Leadership Dispute, Prompting Independent Guidance
The Centers for Disease Control and Prevention (CDC) is experiencing a halt in its vaccine policy recommendations and review process, affecting the approval and guidance for new vaccines like an mRNA flu shot. This disruption stems from actions taken by…
Detroit, MI, September 25, 2026 — The Centers for Disease Control and Prevention (CDC) is currently facing a significant disruption in its vaccine policy recommendations and the review process for new immunizations. This standstill is impacting the potential approval and guidance for vaccines, including novel technologies such as an mRNA flu shot.
The halt in federal vaccine policy development is reportedly linked to actions initiated by Health Secretary Robert F. Kennedy Jr. These actions included efforts to dismiss and replace members of the Advisory Committee on Immunization Practices (ACIP), a key group that advises the CDC on vaccine use and policy.
However, these personnel changes were subsequently blocked by a federal judge, preventing the full implementation of the proposed replacements. The legal intervention has created a complex situation, leaving the official federal guidance on vaccine recommendations stalled.
As a direct consequence of the stalled federal process, independent medical organizations are now stepping in to provide their own recommendations to healthcare providers and the public. This situation highlights a critical gap in authoritative federal guidance, leading to a patchwork of recommendations from various medical bodies. The specific timeline for the resolution of the ACIP leadership dispute and the resumption of the CDC’s standard review processes was not provided.
Story summarized from the original created by Mike Stobbe, Associated Press on www.clickondetroit.com, see more information here.
